TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Jucker Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 140 | 131 | 283 |
Financial expenses | 62 | 18 | 28 |
Earnings before taxes | -79 | 5 | 80 |
EBITDA | -32 | 14 | 101 |
Total assets | 578 | 402 | 468 |
Current assets | 574 | 398 | 464 |
Current liabilities | 461 | 206 | 259 |
Equity capital | 117 | 196 | 209 |
- share capital | 9 | 9 | 10 |
Employees (average) | 2 | 3 | 4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 20.2% | 48.8% | 44.7% |
Turnover per employee | 70 | 44 | 71 |
Profit as a percentage of turnover | -56.4% | 3.8% | 28.3% |
Return on assets (ROA) | -2.9% | 5.7% | 23.1% |
Current ratio | 124.5% | 193.2% | 179.2% |
Return on equity (ROE) | -67.5% | 2.6% | 38.3% |
Change turnover | 8 | -129 | -17 |
Change turnover % | 6% | -50% | -6% |
Chg. No. of employees | -1 | -1 | 0 |
Chg. No. of employees % | -33% | -25% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.